ASND - Ascendis Pharma A/S

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.1B
Enterprise Value 32.69B
Trailing P/E N/A
Forward P/E 1-16.89
PEG Ratio (5 yr expected) 1-0.66
Price/Sales (ttm)7,680.10
Price/Book (mrq)8.74
Enterprise Value/Revenue 36,683.08
Enterprise Value/EBITDA 6-15.42

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018


Profit Margin 0.00%
Operating Margin (ttm)-43,567.63%

Management Effectiveness

Return on Assets (ttm)-33.81%
Return on Equity (ttm)-52.25%

Income Statement

Revenue (ttm)403.08k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-95.40%
Gross Profit (ttm)1.53M
EBITDA -174.65M
Net Income Avi to Common (ttm)-154.12M
Diluted EPS (ttm)-3.87
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)361.53M
Total Cash Per Share (mrq)8.6
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)10.54
Book Value Per Share (mrq)8.43

Cash Flow Statement

Operating Cash Flow (ttm)-148.41M
Levered Free Cash Flow (ttm)-88.26M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.19
52-Week Change 336.40%
S&P500 52-Week Change 3-5.88%
52 Week High 376.99
52 Week Low 348.00
50-Day Moving Average 365.57
200-Day Moving Average 366.19

Share Statistics

Avg Vol (3 month) 3146.88k
Avg Vol (10 day) 3195.82k
Shares Outstanding 542.03M
Float 23.46M
% Held by Insiders 122.43%
% Held by Institutions 147.11%
Shares Short (Dec 31, 2018) 4668.9k
Short Ratio (Dec 31, 2018) 46.53
Short % of Float (Dec 31, 2018) 4N/A
Short % of Shares Outstanding (Dec 31, 2018) 41.59%
Shares Short (prior month Nov 30, 2018) 4820.9k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A